Indications
Therapeutic Asset Ratings
5,099 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Carboplatin
Anal Squamous Cell Carcinoma
Fudan University
P3
B
(60)
Carboplatin
Endometrial Carcinoma
Qilu Pharmaceutical Co., Ltd.
P3
B
(60)
Carboplatin
Hepatoblastoma
Children's Oncology Group
P3
B
(60)
Carboplatin
Mucosal Melanoma
Sun Yat-sen University
P3
B
(60)
Carboplatin
Nervous System Neoplasm
Blueprint Medicines Corporation
P3
B
(60)
Carboplatin
Small Cell Carcinoma
SystImmune Inc.
P3
B
(60)
Carfilzomib
Neoplasm
Fondazione EMN Italy Onlus
P3
B
(60)
Carvedilol
Lymphoma
Mayo Clinic
P3
B
(60)
Catequentinib
Triple-Negative Breast Carcinoma
Jiangsu Cancer Institute & Hospital
P3
B
(60)
Cediranib
Nonpapillary Renal Cell Carcinoma
Roswell Park Cancer Institute
P3
B
(60)
Cediranib
Ovarian Serous Tumor
National Cancer Institute (NCI)
P3
B
(60)
Cenobamate
Generalized Epilepsy
Ono Pharmaceutical Co., Ltd.
P3
B
(60)
Ceritinib
Non-Small Cell Lung Carcinoma
Pfizer
P3
B
(60)
Cetuximab
Pancreatic Neoplasm
Revolution Medicines, Inc.
P3
B
(60)
Cetuximab
Triple-Negative Breast Carcinoma
Pfizer
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Anal Squamous Cell Carcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Bronchogenic Carcinoma
Nanfang Hospital, Southern Medical University
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Malignant Germ Cell Tumor Of Ovary
Children's Oncology Group
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Classic Hodgkin Lymphoma
Cairo University
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Esophageal Adenocarcinoma
Taiho Oncology, Inc.
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Esophageal Squamous Cell Carcinoma
AstraZeneca
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Her2-Receptor Negative Breast Cancer
Peking University First Hospital
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Cirrhosis Of Liver
Institute of Liver and Biliary Sciences, India
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Ovarian Embryonal Carcinoma
Children's Oncology Group
P3
B
(60)
Cis-Diamminedichloroplatinum Ii
Ovarian Yolk Sac Tumor
Children's Oncology Group
P3
B
(60)
Showing 2301 to 2325 of 5,099 assets
Previous
Page 93 of 204
Next